source Post navigation Former Bradford City captain talks type 1 diabetes struggles … – Telegraph and Argus Carmot Therapeutics Commenced Phase 2 Clinical Trial of Novel Dual GLP-1/GIP Receptor Agonist CT-868 for the Treatment of Type 1 Diabetes – Yahoo Finance